Jiangsu Hengrui Pharmaceuticals Co.,Ltd (HKG:1276)

Market Cap	450.54B
Revenue (ttm)	33.86B
Net Income (ttm)	8.16B
Shares Out	n/a
EPS (ttm)	1.27
PE Ratio	55.20
Forward PE	41.24
Dividend	n/a
Ex-Dividend Date	n/a

Volume	202,058
Average Volume	2,855,484
Open	73.55
Previous Close	73.55
Day's Range	73.15 - 73.95
52-Week Range	52.50 - 95.20
Beta	n/a
RSI	45.17
Earnings Date	Mar 26, 2026

About HKG:1276

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. It develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1970
• Employees: 20,238
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1276

Financial Performance

In 2024, HKG:1276's revenue was 27.98 billion, an increase of 22.63% compared to the previous year's 22.82 billion. Earnings were 6.34 billion, an increase of 47.28%.

Financial numbers in CNY